Clinical Trial

Efficacy/ Safety of Product CM9241GRU in Patients With Perennial Allergic Rhinitis

Name: Efficacy/ Safety of Product CM9241GRU in Patients With Perennial Allergic Rhinitis — clinical trial record (NCT06577077)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Study acronym: RESPIRE

Not Yet Recruiting Phase 3

View on ClinicalTrials.gov →

Record status

This record was last updated August 29, 2024 (before its estimated August 2025 completion). Its status may not reflect the trial's current state.

Summary

To evaluate the efficacy and safety of CM9241GRU versus placebo in the treatment of perennial allergic rhinitis.

Trial Details

NCT Number	NCT06577077
Lead Sponsor	Ache Laboratorios Farmaceuticos S.A.
Conditions	Rhinitis, Allergic, Perennial
Enrollment	432 participants
Start Date	2024-09
Primary Completion	2025-08 (estimated)
Study Completion	2025-08 (estimated)
Updated on ClinicalTrials.gov	2024-08-29